v3.26.1
Condensed Consolidated Statements of Operations and Other Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Income Statement [Abstract]    
License and collaboration revenue $ 31,738 $ 7,470
Revenue, Product and Service [Extensible List] us-gaap:LicenseMember us-gaap:LicenseMember
Operating expenses:    
Research and development $ 104,524 $ 98,816
General and administrative 34,429 27,940
Total operating expenses 138,953 126,756
Loss from operations (107,215) (119,286)
Other income (expense):    
Change in fair value of derivative liabilities 2,500 3,200
Change in fair value of non-controlling equity investments 16 (2,081)
Change in fair value of contingent consideration liabilities 514 (27)
Interest and other income (expense), net 9,867 9,864
Total other income (expense) 12,897 10,956
Net loss (94,318) (108,330)
Unrealized gain (loss) on marketable securities (2,181) (519)
Comprehensive loss $ (96,499) $ (108,849)
Net loss per common share, basic $ (0.91) $ (1.23)
Net loss per common share, diluted $ (0.91) $ (1.23)
Weighted - average common shares outstanding, basic 103,262,001 87,975,311
Weighted - average common shares outstanding, diluted 103,262,001 87,975,311